Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Supply, Demand and Key Producers, 2024-2030

Page: 105

Published Date: 07 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent refers to an inactivated split influenza vaccine whose vaccine components include A (H3N2) subtype, A (H1N1) pdm09 subtype, and type B Victoria and Yamagata lines.

The global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Influenza Vaccine (Split Virion), Inactivated, Quadrivalent and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent total production and demand, 2019-2030, (K Units)
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent total production value, 2019-2030, (USD Million)
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent domestic production, consumption, key domestic manufacturers and share
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hualan Bacterin, Sinovac Biotech, Sanofi, CSL Seqirus, GSK, Adimmune, Sinopharm, Jiangsu GDK Biotechnology, Abbott, Ab&B BIO-TECH, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market, Segmentation by Type:
    Child
    Adult
    Elder

Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market, Segmentation by Application:
    Hospital
    Clinic

Companies Profiled:
    Hualan Bacterin
    Sinovac Biotech
    Sanofi
    CSL Seqirus
    GSK
    Adimmune
    Sinopharm
    Jiangsu GDK Biotechnology
    Abbott
    Ab&B BIO-TECH

Key Questions Answered:
1. How big is the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market?
2. What is the demand of the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market?
3. What is the year over year growth of the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market?
4. What is the production and production value of the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market?
5. Who are the key producers in the global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Introduction
    1.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Supply & Forecast
        1.2.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value (2019 & 2023 & 2030)
        1.2.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030)
        1.2.3 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Pricing Trends (2019-2030)
    1.3 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Region (Based on Production Site)
        1.3.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Region (2019-2030)
        1.3.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Region (2019-2030)
        1.3.3 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Region (2019-2030)
        1.3.4 North America Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030)
        1.3.5 Europe Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030)
        1.3.6 China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030)
        1.3.7 Japan Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Major Market Trends

2 Demand Summary
    2.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Demand (2019-2030)
    2.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption by Region
        2.2.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption by Region (2019-2024)
        2.2.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Forecast by Region (2025-2030)
    2.3 United States Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)
    2.4 China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)
    2.5 Europe Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)
    2.6 Japan Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)
    2.7 South Korea Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)
    2.8 ASEAN Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)
    2.9 India Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Manufacturer (2019-2024)
    3.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Manufacturer (2019-2024)
    3.3 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Manufacturer (2019-2024)
    3.4 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in 2023
        3.5.3 Global Concentration Ratios (CR8) for Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in 2023
    3.6 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market: Overall Company Footprint Analysis
        3.6.1 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market: Region Footprint
        3.6.2 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market: Company Product Type Footprint
        3.6.3 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Comparison
        4.1.1 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Comparison
        4.2.1 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Comparison
        4.3.1 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2024)
    4.5 China Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers and Market Share
        4.5.1 China Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value (2019-2024)
        4.5.3 China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2024)
    4.6 Rest of World Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2024)

5 Market Analysis by Type
    5.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Child
        5.2.2 Adult
        5.2.3 Elder
    5.3 Market Segment by Type
        5.3.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Type (2019-2030)
        5.3.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Type (2019-2030)
        5.3.3 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Application (2019-2030)
        6.3.2 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Application (2019-2030)
        6.3.3 World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Hualan Bacterin
        7.1.1 Hualan Bacterin Details
        7.1.2 Hualan Bacterin Major Business
        7.1.3 Hualan Bacterin Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.1.4 Hualan Bacterin Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Hualan Bacterin Recent Developments/Updates
        7.1.6 Hualan Bacterin Competitive Strengths & Weaknesses
    7.2 Sinovac Biotech
        7.2.1 Sinovac Biotech Details
        7.2.2 Sinovac Biotech Major Business
        7.2.3 Sinovac Biotech Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.2.4 Sinovac Biotech Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Sinovac Biotech Recent Developments/Updates
        7.2.6 Sinovac Biotech Competitive Strengths & Weaknesses
    7.3 Sanofi
        7.3.1 Sanofi Details
        7.3.2 Sanofi Major Business
        7.3.3 Sanofi Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.3.4 Sanofi Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Sanofi Recent Developments/Updates
        7.3.6 Sanofi Competitive Strengths & Weaknesses
    7.4 CSL Seqirus
        7.4.1 CSL Seqirus Details
        7.4.2 CSL Seqirus Major Business
        7.4.3 CSL Seqirus Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.4.4 CSL Seqirus Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 CSL Seqirus Recent Developments/Updates
        7.4.6 CSL Seqirus Competitive Strengths & Weaknesses
    7.5 GSK
        7.5.1 GSK Details
        7.5.2 GSK Major Business
        7.5.3 GSK Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.5.4 GSK Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 GSK Recent Developments/Updates
        7.5.6 GSK Competitive Strengths & Weaknesses
    7.6 Adimmune
        7.6.1 Adimmune Details
        7.6.2 Adimmune Major Business
        7.6.3 Adimmune Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.6.4 Adimmune Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Adimmune Recent Developments/Updates
        7.6.6 Adimmune Competitive Strengths & Weaknesses
    7.7 Sinopharm
        7.7.1 Sinopharm Details
        7.7.2 Sinopharm Major Business
        7.7.3 Sinopharm Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.7.4 Sinopharm Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Sinopharm Recent Developments/Updates
        7.7.6 Sinopharm Competitive Strengths & Weaknesses
    7.8 Jiangsu GDK Biotechnology
        7.8.1 Jiangsu GDK Biotechnology Details
        7.8.2 Jiangsu GDK Biotechnology Major Business
        7.8.3 Jiangsu GDK Biotechnology Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.8.4 Jiangsu GDK Biotechnology Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Jiangsu GDK Biotechnology Recent Developments/Updates
        7.8.6 Jiangsu GDK Biotechnology Competitive Strengths & Weaknesses
    7.9 Abbott
        7.9.1 Abbott Details
        7.9.2 Abbott Major Business
        7.9.3 Abbott Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.9.4 Abbott Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Abbott Recent Developments/Updates
        7.9.6 Abbott Competitive Strengths & Weaknesses
    7.10 Ab&B BIO-TECH
        7.10.1 Ab&B BIO-TECH Details
        7.10.2 Ab&B BIO-TECH Major Business
        7.10.3 Ab&B BIO-TECH Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
        7.10.4 Ab&B BIO-TECH Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Ab&B BIO-TECH Recent Developments/Updates
        7.10.6 Ab&B BIO-TECH Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Industry Chain
    8.2 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Upstream Analysis
        8.2.1 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Core Raw Materials
        8.2.2 Main Manufacturers of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Mode
    8.6 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Procurement Model
    8.7 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Industry Sales Model and Sales Channels
        8.7.1 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Sales Model
        8.7.2 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Region (2019-2024)
 Table 5. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Region (2025-2030)
 Table 6. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Region (2019-2024) & (K Units)
 Table 7. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Region (2025-2030) & (K Units)
 Table 8. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share by Region (2019-2024)
 Table 9. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share by Region (2025-2030)
 Table 10. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Major Market Trends
 Table 13. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption by Region (2019-2024) & (K Units)
 Table 15. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Producers in 2023
 Table 18. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Producers in 2023
 Table 20. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Company Evaluation Quadrant
 Table 22. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Site of Key Manufacturer
 Table 24. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market: Company Product Type Footprint
 Table 25. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market: Company Product Application Footprint
 Table 26. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Competitive Factors
 Table 27. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent New Entrant and Capacity Expansion Plans
 Table 28. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Mergers & Acquisitions Activity
 Table 29. United States VS China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share (2019-2024)
 Table 37. China Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share (2019-2024)
 Table 42. Rest of World Based Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share (2019-2024)
 Table 47. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Type (2019-2024) & (K Units)
 Table 49. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Type (2025-2030) & (K Units)
 Table 50. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Application (2019-2024) & (K Units)
 Table 56. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production by Application (2025-2030) & (K Units)
 Table 57. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Hualan Bacterin Basic Information, Manufacturing Base and Competitors
 Table 62. Hualan Bacterin Major Business
 Table 63. Hualan Bacterin Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 64. Hualan Bacterin Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Hualan Bacterin Recent Developments/Updates
 Table 66. Hualan Bacterin Competitive Strengths & Weaknesses
 Table 67. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
 Table 68. Sinovac Biotech Major Business
 Table 69. Sinovac Biotech Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 70. Sinovac Biotech Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Sinovac Biotech Recent Developments/Updates
 Table 72. Sinovac Biotech Competitive Strengths & Weaknesses
 Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 74. Sanofi Major Business
 Table 75. Sanofi Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 76. Sanofi Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Sanofi Recent Developments/Updates
 Table 78. Sanofi Competitive Strengths & Weaknesses
 Table 79. CSL Seqirus Basic Information, Manufacturing Base and Competitors
 Table 80. CSL Seqirus Major Business
 Table 81. CSL Seqirus Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 82. CSL Seqirus Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. CSL Seqirus Recent Developments/Updates
 Table 84. CSL Seqirus Competitive Strengths & Weaknesses
 Table 85. GSK Basic Information, Manufacturing Base and Competitors
 Table 86. GSK Major Business
 Table 87. GSK Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 88. GSK Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. GSK Recent Developments/Updates
 Table 90. GSK Competitive Strengths & Weaknesses
 Table 91. Adimmune Basic Information, Manufacturing Base and Competitors
 Table 92. Adimmune Major Business
 Table 93. Adimmune Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 94. Adimmune Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Adimmune Recent Developments/Updates
 Table 96. Adimmune Competitive Strengths & Weaknesses
 Table 97. Sinopharm Basic Information, Manufacturing Base and Competitors
 Table 98. Sinopharm Major Business
 Table 99. Sinopharm Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 100. Sinopharm Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Sinopharm Recent Developments/Updates
 Table 102. Sinopharm Competitive Strengths & Weaknesses
 Table 103. Jiangsu GDK Biotechnology Basic Information, Manufacturing Base and Competitors
 Table 104. Jiangsu GDK Biotechnology Major Business
 Table 105. Jiangsu GDK Biotechnology Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 106. Jiangsu GDK Biotechnology Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Jiangsu GDK Biotechnology Recent Developments/Updates
 Table 108. Jiangsu GDK Biotechnology Competitive Strengths & Weaknesses
 Table 109. Abbott Basic Information, Manufacturing Base and Competitors
 Table 110. Abbott Major Business
 Table 111. Abbott Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 112. Abbott Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Abbott Recent Developments/Updates
 Table 114. Abbott Competitive Strengths & Weaknesses
 Table 115. Ab&B BIO-TECH Basic Information, Manufacturing Base and Competitors
 Table 116. Ab&B BIO-TECH Major Business
 Table 117. Ab&B BIO-TECH Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Product and Services
 Table 118. Ab&B BIO-TECH Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Ab&B BIO-TECH Recent Developments/Updates
 Table 120. Ab&B BIO-TECH Competitive Strengths & Weaknesses
 Table 121. Global Key Players of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Upstream (Raw Materials)
 Table 122. Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Typical Customers
 Table 123. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Typical Distributors


List of Figures
 Figure 1. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Picture
 Figure 2. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030) & (K Units)
 Figure 5. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Region (2019-2030)
 Figure 7. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share by Region (2019-2030)
 Figure 8. North America Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030) & (K Units)
 Figure 9. Europe Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030) & (K Units)
 Figure 10. China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030) & (K Units)
 Figure 11. Japan Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production (2019-2030) & (K Units)
 Figure 12. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 15. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Market Share by Region (2019-2030)
 Figure 16. United States Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 17. China Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 18. Europe Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 19. Japan Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 22. India Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Markets in 2023
 Figure 26. United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share 2023
 Figure 30. China Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share 2023
 Figure 32. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Type in 2023
 Figure 34. Child
 Figure 35. Adult
 Figure 36. Elder
 Figure 37. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share by Type (2019-2030)
 Figure 38. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Type (2019-2030)
 Figure 39. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Application in 2023
 Figure 42. Hospital
 Figure 43. Clinic
 Figure 44. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Market Share by Application (2019-2030)
 Figure 45. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Production Value Market Share by Application (2019-2030)
 Figure 46. World Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Average Price by Application (2019-2030) & (US$/Unit)
 Figure 47. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Industry Chain
 Figure 48. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Procurement Model
 Figure 49. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Sales Model
 Figure 50. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Hualan Bacterin
Sinovac Biotech
Sanofi
CSL Seqirus
GSK
Adimmune
Sinopharm
Jiangsu GDK Biotechnology
Abbott
Ab&B BIO-TECH

Related Reports

Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Influenza Vaccine (Split Virion), Inactivated, Quadrivalent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 07 Apr 2024

date Pharma & Healthcare

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent refers to an inactivated split influenza vaccine whose vaccine components include A (H3N2) subtype, A (H1N1) pdm09 subtype, and type B Victoria and Yamagata lines.

Product Tags

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>